Thomas J. LaSalle - Concepedia

Author

Thomas J. LaSalle

Also Known As

Irena Gushterova, Karl R. Clauser, LaSalle, Thomas, LaSalle, Thomas J., Mei-An Nolan, C., Thomas J LaSalle, Thomas J. LaSalle, Thomas James LaSalle, Thomas LaSalle, Tom LaSalle

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Massachusetts General Hospital Broad Institute Harvard University Dana-Farber Cancer Institute Massachusetts Institute of Technology

About

Thomas J. LaSalle is an author at Massachusetts General Hospital specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	301
2	Cell Biology	3	3	98
3	Immunology	3	3	227
4	Natural Sciences	1	1	29
5	Allergy	1	1	47

Thomas J. LaSalle

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions Michael R. Filbin, Arnav Mehta, Alexis M. Schneider, Cell Reports Medicine	2021	299
Targeting TBK1 to overcome resistance to cancer immunotherapy Yi Sun, Or‐Yam Revach, Seth Anderson, Nature Tumor BiologyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorImmunotherapy	2023	156
SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Yijia Li, Alexis M. Schneider, Arnav Mehta, Journal of Clinical Investigation	2021	118
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 Paulina Kapłonek, Chuangqi Wang, Yannic C. Bartsch, Science Immunology	2021	85
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients Thomas J. LaSalle, Anna Gonye, Samuel S. Freeman, Cell Reports Medicine	2022	66
Granzyme B PET imaging of immune-mediated tumor killing as a tool for understanding immunotherapy response Thomas J. LaSalle, Emily Austin, Grant Rigney, Journal for ImmunoTherapy of Cancer	2020	63
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patients Michael R. Filbin, Arnav Mehta, Alexis M. Schneider,	2020	49
Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children Brittany P. Boribong, Thomas J. LaSalle, Yannic C. Bartsch, Cell Reports Medicine Multisystem Inflammatory SyndromeImmunodeficienciesInnate Immune SystemImmunologyNet Release	2022	47
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma Carlos Sebastián, Christina M. Ferrer, Caroline A. Lewis, Nature Metabolism OncologySquamous Cell CarcinomaMedicineUnique SubsetGlycolytic Tumour-propagating Cells	2021	45
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim, Cell Reports Medicine	2022	34

Page 1